Filing Details

Accession Number:
0001140361-10-042420
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-10-27 16:30:33
Reporting Period:
2010-10-26
Filing Date:
2010-10-27
Accepted Time:
2010-10-27 16:30:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884731 Ariad Pharmaceuticals Inc ARIA Biological Products, (No Disgnostic Substances) (2836) 223106987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242992 P Timothy Clackson C/O Ariad Pharmaceuticals, Inc.
26 Landsdowne Street
Cambridge MA 02139
Pres., R & D., Chief Sci. Off. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-10-26 10,000 $3.70 117,437 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. These shares were purchased in a public offering of 16 million shares of ARIAD common stock priced on 10/26/2010 and closing on 10/29/2010.